Cargando…
The biofunctionalization of titanium nanotube with chitosan/genipin heparin hydrogel and the controlled release of IL-4 for anti-coagulation and anti-thrombus through accelerating endothelialization
The valve replacement is the main treatment of heart valve disease. However, thrombus formation following valve replacement has always been a major clinical drawback. Accelerating the endothelialization of cardiac valve prosthesis is the main approach to reduce thrombus. In the current study, a tita...
Autores principales: | Yu, Wen Peng, Gong, Yi, Wang, Ziyao, Lu, Chao, Ding, Jing Li, Liu, Xin Liang, Zhu, Guo Dong, Lin, Feng, Xu, Jian Jun, Zhou, Jian Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031326/ https://www.ncbi.nlm.nih.gov/pubmed/35479169 http://dx.doi.org/10.1039/d0ra09295a |
Ejemplares similares
-
Systematic Review of Effectiveness of Chitosan as a Biofunctionalizer of Titanium Implants
por: López-Valverde, Nansi, et al.
Publicado: (2021) -
Chitosan-Genipin Microspheres for the Controlled Release of Drugs: Clarithromycin, Tramadol and Heparin
por: Harris, Ruth, et al.
Publicado: (2010) -
Heparin beyond anti-coagulation
por: Chen, Daohong
Publicado: (2021) -
Fluorescence Imaging in Genipin Crosslinked Chitosan–Poly(vinyl pyrrolidone) Hydrogels
por: Matcham, Simon, et al.
Publicado: (2016) -
Assessment of Cytocompatibility and Anti-Inflammatory (Inter)Actions of Genipin-Crosslinked Chitosan Powders
por: Dimida, Simona, et al.
Publicado: (2020)